Get started
Author

Faye A. H. Cooles

Observed names: Cooles, Faye, F A H Cooles, F. A. H. Cooles, F.A. Cooles, F.A.H. Cooles, Faye A H Cooles, Faye A. H Cooles, Faye A.H. Cooles, Faye A.H. Cooles ve John D. Isaacs, Faye AH Cooles, Faye Anisa Hogarth Cooles, Faye Cooles
Observed institutions: University of British Columbia, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne Hospital, NIHR Newcastle Biomedical Research Centre, Arthritis Research UK, Newcastle University, University of Edinburgh
ORCID: 0000-0002-8529-3337
Observed ORCID: 0000-0002-8529-3337
OpenAlex ID: A5021451679
Pathophysiology of rheumatoid arthritis
2011 · Faye AH Cooles, John D Isaacs · Current Opinion in Rheumatology · 186
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial
2024 · Andrew P Cope, Marianna Jasenecova, et al. · The Lancet · 183
PDF
Basic Mechanisms of JAK Inhibition
2020 · Chung MA Lin, Faye AH Cooles, et al. · Mediterranean Journal of Rheumatology · 126
PDF
Treg Cells in Rheumatoid Arthritis: An Update
2013 · Faye A. H. Cooles, John D. Isaacs, et al. · Current Rheumatology Reports · 102
Is undergraduate medical education working for ENT surgery? A survey of UK medical school graduates
2011 · J Powell, F A H Cooles, et al. · The Journal of Laryngology & Otology · 77
Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming
2022 · Faye A H Cooles, Jessica Tarn, et al. · Annals of the Rheumatic Diseases · 67
PDF
The interferon gene signature is increased in patients with early treatment-naive rheumatoid arthritis and predicts a poorer response to initial therapy
2017 · Faye A.H. Cooles, Amy E. Anderson, et al. · Journal of Allergy and Clinical Immunology · 62
PDF
Precision medicine: the precision gap in rheumatic disease
2022 · Chung M. A. Lin, Faye A. H. Cooles, et al. · Nature Reviews Rheumatology · 45
Phenotypic and Transcriptomic Analysis of Peripheral Blood Plasmacytoid and Conventional Dendritic Cells in Early Drug Naïve Rheumatoid Arthritis
2018 · Faye A. H. Cooles, Amy E. Anderson, et al. · Frontiers in Immunology · 37
PDF
The interferon gene signature as a clinically relevant biomarker in autoimmune rheumatic disease
2021 · Faye A H Cooles, John D Isaacs · The Lancet Rheumatology · 35
Excess Mucin Impairs Subglottic Epithelial Host Defense in Mechanically Ventilated Patients
2018 · Jason Powell, James P. Garnett, et al. · American Journal of Respiratory and Critical Care Medicine · 30
PDF
Role of IFN-α in Rheumatoid Arthritis
2023 · Chung M. A. Lin, John D. Isaacs, et al. · Current Rheumatology Reports · 29
PDF
RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients
2022 · John D. Isaacs, Sarah Brockbank, et al. · Scientific Data · 25
PDF
Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapies
2016 · Faye A. H. Cooles, Amy E. Anderson, et al. · Arthritis Research & Therapy · 24
PDF
Emerging immunotherapies for rheumatoid arthritis
2014 · Gary Reynolds, Faye AH Cooles, et al. · Human Vaccines & Immunotherapeutics · 21
PDF
Long-term outcomes of abatacept in individuals at risk of developing rheumatoid arthritis (ALTO): a randomised, double-blind, placebo-controlled trial
2026 · Andrew P Cope, Marianna Jasenecova, et al. · The Lancet Rheumatology · 11
Epstein-Barr virus-driven lymphoproliferative disorder post-CAMPATH-1H (alemtuzumab) in refractory polymyositis
2011 · F. A. H. Cooles, G. H. Jackson, et al. · Lara D. Veeken · 11
Retrospective analysis of the role of serum vitamin D in early rheumatic disease
2014 · F. A. H. Cooles, A. G. Pratt, et al. · Lara D. Veeken · 6
Treating to re-establish tolerance in inflammatory arthritis – lessons from other diseases
2010 · Faye A.H. Cooles, John D. Isaacs · Best Practice & Research Clinical Rheumatology · 6
Prevalence and diagnostic outcome relating to vitamin D deficiency in new patients presenting to an early arthritis clinic over 12 months
2011 · Faye A. H. Cooles, Arthur G. Pratt, et al. · Clinical Rheumatology · 4
Endogenous Retroelement Activation is Implicated in Interferon‐α Production and Anti–Cyclic Citrullinated Peptide Autoantibody Generation in Early Rheumatoid Arthritis
2024 · Faye A. H. Cooles, Gemma Vidal Pedrola, et al. · Arthritis & Rheumatology · 3
PDF
P34 Early-onset neutropenia in rituximab treated rheumatoid arthritis patients: a case series
2020 · Chung Mun Alice Lin, Alice R Lorenzi, et al. · Lara D. Veeken · 2
PDF
E167 A case of G-CSF Induced Aortitis
2026 · Eleanor Burnett, Asma Abdul Malek, et al. · Lara D. Veeken
Rheumatoid arthritis and osteoarthritis patients demonstrate comparable rates of major adverse cardiovascular events: a single-centre retrospective cohort study
2025 · Chung M A Lin, Hadeel M Tabaqchali, et al. · Rheumatology Advances in Practice
Abs0847 Retrospective Single-centre Analysis of Survival and Safety Signals in Autoimmune Rheumatic Disease Patients Undergoing Lung Transplantation
2025 · F.A. Cooles, A. Obrzut, et al. · Annals of the Rheumatic Diseases
Works count: 42
Citation count: 1,092
H-index: 15
I10-index: 17
Year
Topic
Type